Corrigendum to "Mimicking brain tissue binding in an in vitro model of the blood-brain barrier illustrates differences between in vitro and in vivo methods for assessing the rate of brain penetration" [Eur. J. Pharm. Biopharm. 127 (2018) 453-461]
Eur J Pharm Biopharm
.
2018 Dec:133:200-202.
doi: 10.1016/j.ejpb.2018.10.012.
Epub 2018 Oct 27.
Authors
Marjolein Heymans
1
,
Emmanuel Sevin
1
,
Fabien Gosselet
1
,
Stefan Lundquist
2
,
Maxime Culot
3
Affiliations
1
Univ. Artois, EA 2465 - Blood-Brain Barrier Laboratory (LBHE), F-62300 Lens, France.
2
Local DMPK Department, AstraZeneca R&D, Södertälje, Sweden.
3
Univ. Artois, EA 2465 - Blood-Brain Barrier Laboratory (LBHE), F-62300 Lens, France. Electronic address:
[email protected]
.
PMID:
30458954
DOI:
10.1016/j.ejpb.2018.10.012
No abstract available
Publication types
Published Erratum